कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
HNSA | स्टॉकहोल्म | SEK | रियल टाइम | |
HNSAs | BATS Europe | SEK | देरी | |
24H | फ़्रंकफ़र्ट | EUR | देरी |
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Europe and the United States.The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing Novel immunoglobulin cleaving enzymes for Repeat dosing (NiceR) for the treatment of autoimmune diseases, transplantation, and oncology; and Enzyme based antibody Enhancement (EnzE), which is cancer immunotherapy. The company has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Mats Peter Blom | 58 | 2019 | Independent Director |
Andreas Eggert | 56 | 2018 | Independent Director |
Anders Gersel Pedersen | 72 | 2018 | Independent Director |
Gunnar Tufveson | - | - | Chairman of European Medical Advisory Board in Transplantation |
Stanley Jordan | - | - | Chairman of US Medical Advisory Board in Transplantation |
Robert A. Montgomery | - | - | Member of US Medical Advisory Board in Transplantation |
Christophe Legendre | - | - | Member of European Medical Advisory Board in Transplantation |
Kathryn Wood | - | - | Member - European Medical Advisory Board-Transplantation & US Medical Advisory Board-Transplantation |
Hilary M. Malone | 58 | 2021 | Independent Director |
Eva Nilsagard | 59 | 2019 | Independent Director |
Peter Nicklin | 60 | 2022 | Independent Chairman of the Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है